Sees FY23 adjusted EBITDA $180M-$200M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EVH:
- Evolent Health Announces Fourth Quarter and Full Year 2022 Results
- Evolent Health price target raised to $59 from $57 at Cowen
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- Evolent Health jumps after announcing expansion of Humana pact
- Evolent Health price target raised to $51 from $44 at Piper Sandler